| Entry |
|
|---|
| Name |
Pegbelfermin (USAN) |
|---|
| Formula |
C874H1352N242O264S3. (C2H4O)n
|
|---|
| Sequence |
MHPIPDSSPL LQFGGQVRQR YLYTDDAQQT EAHLEIREDG TVGGAADQSP ESLLQLKALK
PGVIQILGVK TSRFLCQRPD GALYGSLHFD PEACSFRELL LEDGYNVYFS EAHGLPLHLP
GNKSPHRDPA PRGPARFLPL PGLPPAPPEP PGILAPQPPD VGSSDPLSMV GPSQGRSPSY
AS
(Disulfide bridge: 76-94) |
|---|
| Type |
Peptide |
|---|
| Efficacy |
Antifibrotic, Fibroblast growth factor replacement |
|---|
| Comment |
Treatment of liver fibrosis; NASH (non-alcoholic steatohepatitis)
|
|---|
| Target |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Signaling molecules and receptors
Cytokines
Growth factors (RTK-binding)
FGF21
D11512 Pegbelfermin (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
